The value of MRS integratel MRI in the differential diagnosis of prostate adenocarcinoma and benign prostate hyperplasia

ZHANG Lin-lin,YUAN Shu-guang,YAN Dong,ZHAO Xin-xiang,GUO Li,MA Yue

DOI: https://doi.org/10.3969/j.issn.1006-9011.2008.05.019

2008-01-01

Journal of Medical Imaging

Abstract:Objective:To describe MR imaging (MRI) and spectroscopic (MRS) appearances of prostate adenocarcinoma and benign prostate hyperplasia and to evaluate MRS connecting with MRI in the differential diagnosis of prostate adenocarcinoma and benign prostate hyperplasia.Methods:Clinical date together with MRI and MRS findings were reviewed in 26 cases with pathologically confirmed prostate diseases and 32 cases of benign prostate hyperplasia. MRI observation was focused on the size of the gland, the location of the lesion, the signal features and the extent of the tumor. MRS observations included the chemical shift of citrate (Cit), choline (Cho) and creatine (Cr) spectra, and the ratio of Citr+Cho/Cr.Results:On MRI, 20 cases had apparent sign of pc, of these, the affected structures included seminal vesicle (n=18), bladder (n=14), bone of pelvic (n=12), rectum (n=5) and pelvic lymph nodes fused in mass (n=5). While, no apparent sign of PCa was found in 6 cases. On MRS, prostate was divided into four regions and marked cancer point on MRS metabolic picture. Six cancer points were abstracted from every case, in all 58 cases, 232 points were selected, Cit peak was obviously declined and choline peak was ascended of prostate cancer. The average ratio of Cho+Cre/Cit for prostate cancer was 2.3730±1.97548, benign prostate hyperplasias' was 0.5450±0.48842.Conclusion:MRI can well display localization of tumor and detect extracapsular spread of disease. MRS can provide the quantitative analysis and metabolic information of PCa or suspected position. MRS together with MRI can improve the experience of the radiologists and may have an important value of diagnosis.